KEYS vs MGNX · P/E 57, rev $5.16B vs rev $39.6M
Keysight Technologies Inc (KEYS) versus MacroGenics Inc (MGNX) — a side-by-side from cached financials, not a winner call.
Keysight Technologies Inc (KEYS) is a scientific & technical instruments company listed on US.
MacroGenics Inc (MGNX) is a biotechnology company listed on NASDAQ.
Latest reported KEYS revenue for 2026-07-31 was $5.16B. Net income was $1.03B. Revenue was up 55.7% from 2026-04-30 to 2026-07-31. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
Latest reported MGNX revenue for 2026-06-30 was $39.6M. Net income was -$17.3M. Revenue was up 90.4% from 2026-03-31 to 2026-06-30. MGNX currently screens at market cap $246.6M.
KEYS currently screens at market cap $59.84B and trailing P/E 56.5. MGNX currently screens at market cap $246.6M.
Not investment advice. Open the KEYS and MGNX stock pages for the full models.
Not investment advice.